
2020幎2æ27æ¥ãã¯ã¯ãã³ã¯çç©å µåšå¯Ÿçãšãªã£ãââãã³ã¿ãŽã³ãšNSCãææ¡ãããã³ãããã¯
ç§ãçºèŠããã®ã¯ãç±³åœã®Covidãã³ãããã¯å¯Ÿå¿ãHHSãCDCãã®ä»ã®å ¬è¡è¡çæ©é¢ã«ãã£ãŠéå¶ããããã®ã§ã¯ãªãã£ããšããããšã ãããã¯ãã³ã¿ãŽã³ãåœå®¶å®å šä¿éäŒè°ãåœåå®å šä¿éçã«ãã£ãŠéå¶ããããçç©é²è¡ã»å¯Ÿãã察å¿ã ã£ãã
ãããããéåžžã®å ¬è¡è¡ç察å¿ã ã£ããªããCovidã¯éå»äžäžçŽã®ã©ã®ãŠã€ã«ã¹æµè¡ã»ãã³ãããã¯ãšãå€ãããªãã£ãã ããã
ã¯ããã«
2020幎2æ4æ¥ãç±³åœå ã®Covid-19ææè ã¯ããã11äººãæ»è ã¯ãŒãã ã£ãã
ãã®æ¥ãåœé²ç·çã¯ã¢ã¹ãã©ãŒãã«ã®å¹¹éšã«é»è©±ããããããéåããââãæ°ãã«çºèŠãããSARS-2ãŠã€ã«ã¹ã¯åœå®¶å®å šä¿éäžã®è åšã§ããããšã忥ãFDAãšHHSã¯ç·æ¥äœ¿çšèš±å¯ïŒEUAïŒãšPREPæ³ã®çºåæ ¹æ ã宣èšããããŠã¢ã³ãœããŒã»ãã¡ãŠããã¯ããŠã€ã«ã¹ã¯å®éšå®€èµ·æºã§ã¯ãªãããšãã声ææã®èª¿æŽãå§ããŠããã
11äººã®ææè ã§åœå®¶å®å šä¿éäžã®è åšãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ã§ããæ¯å¹Žæ°äžäººãæ»äº¡ããåœã§ãã§ããã
ãã®äžç¹ã®éåæããããããŒã»ã©ãŒãã³ã¯èª¿æ»ãå§ãããå ãªãã©ã«å·ŠæŽŸã§NYTãšNPRãä¿¡é ŒããŠãã圌女ãããã³ãããã¯å¯Ÿå¿ã®è£ã«äœãèŠã€ããã®ãã2025幎ã«Brownstone Instituteããåè¡ããããThe Deep State Goes Viral: Pandemic Planning and the Covid Coupãã¯ãCovid-19ãã³ãããã¯ãå ¬è¡è¡çæ¿çã§ã¯ãªããè»äºã»è«å ±ã»è£œè¬è€åäœã«ãããçç©é²è¡ã¯ãŒãã¿ãŒãã ã£ãããšããææžèšŒæ ã®ç©ã¿äžãã«ãã£ãŠæãåºãã
ãããŠä»ããã¡ãŠãã®æ¥èšå ¬éã«ãã£ãŠãæ¬æžã®åæã¯æ°ããªæ€èšŒã®å ã«æãããŠããã
èè ã»æžç±ç޹ä»
ãããŒã»ã©ãŒãã³ïŒDebbie LermanïŒã¯ãBrownstone Instituteã®å¯çš¿è ã2020幎以åã¯ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºãNPRãä¿¡é Œãããªãã©ã«å·ŠæŽŸã®æ°äž»å æ¯æè ã ã£ãããã³ãããã¯å¯Ÿå¿ãžã®ç念ããã£ããã«äž»æµã¡ãã£ã¢ãžã®ä¿¡é Œã倱ããSubstackã§ç¬èªã®èª¿æ»çºä¿¡ãéå§ãæ¬æžã¯ãã®é倧æã§ããã

ãThe Deep State Goes Viral: Pandemic Planning and the Covid CoupãïŒBrownstone Instituteã2025幎ãçŽ300ããŒãžïŒã¯ãCovid-19ãã³ãããã¯å¯Ÿå¿ããåœå®¶å®å šä¿éã»çç©é²è¡ã®æ çµã¿ã§å®è¡ãããæ·±å±€åœå®¶ã«ããã¯ãŒãã¿ãŒããšããŠåæãã調æ»å ±åã§ããã
å š6ç« æ§æã§ãNSCïŒåœå®¶å®å šä¿éäŒè°ïŒã«ããæ¿çææ¡ãmRNAã¯ã¯ãã³ã®è»äºèª¿éã2020幎2æ27æ¥ã®äžççãããã¬ã³ãåæçºåãååœã®è»äºçµ±å¶äœå¶ãªã©ãææžèšŒæ ããå®èšŒãããåºæã¯Brownstone Instituteåµèšè ã®ãžã§ããªãŒã»ã¿ãã«ãŒã
1 å·æŠåŸãè»ç£è€åäœã¯ãæ°ããªæµããå¿ èŠãšãã
æŠæŒ¢ã§SARS-CoV-2ãåºçŸããªãã£ããšããŠããã©ããå¥ã®å Žæã§å¥ã®ããªã¬ãŒã€ãã³ããèµ·ããŠããã ããââãããŠäžççãã³ãããã¯å¯Ÿå¿ã¯ãŸã£ããåãã ã£ãã ããã
æ¬æžã®äžå¿åœé¡ã¯æå¿«ã ãCovid-19ãã³ãããã¯å¯Ÿå¿ã¯ã衚åãã«ã¯å ¬è¡è¡çæ¿çãšããŠè£ ãããŠãããã宿 ã¯åœå®¶å®å šä¿éã»çç©é²è¡ïŒbiodefenseïŒã®æ çµã¿ã§å®è¡ãããè»äºäœæŠã ã£ãããããŠãã®äœæŠãäž»å°ããã®ã¯ãCDCã§ãWHOã§ããªããè»äºã»è«å ±ã»è£œè¬ã»è²¡å£ãçµã³ã€ãããçç©é²è¡ã°ããŒãã«å ¬å ±æ°éããŒãããŒã·ããïŒGPPPïŒãã§ããã
ã©ãŒãã³ã¯ãã®æ§é ããå·æŠçµçµåŸã®è»ç£è€åäœã®å€é·ãã説ãèµ·ãããå·æŠãšãããæµãã倱ã£ãè»ç£è€åäœã¯ã9/11ãšççœèäºä»¶ãçµãŠããã€ãªãããšã®æŠäºããšããæ°ããªåçæºãåµåºããããã€ãªé²è¡äºç®ã¯2001幎ã®çŽ7åãã«ãã2002幎ã«ã¯çŽ40åãã«ã2005幎ã«ã¯çŽ80åãã«ãžãšèšåŒµãã20幎éã§ç·é¡1,000åãã«è¶ ã«éããã
ãã®äºç®ã®åãç¿ãšããŠåœ¢æãããã®ãGPPPã ããã®æ§æå¡ã¯ââè»äºæ©é¢ïŒDARPAãBARDAãDTRAïŒãè«å ±æ©é¢ïŒCIAãNSCïŒãåœéåçïŒNATOããã¡ã€ãã»ã¢ã€ãºïŒã補è¬äŒæ¥ïŒãã¡ã€ã¶ãŒãã¢ãã«ãïŒã財å£ïŒã²ã€ã財å£ããŠã§ã«ã«ã ã»ãã©ã¹ãïŒãåœéæ©é¢ïŒWHOãWEFïŒââãšãéåžžã®ãå ¬è¡è¡çãã®æ ãé¥ãã«è¶ ããã
ã©ãŒãã³ã®åæã§æãæŠæ ãã¹ãã¯ããã®å·šå€§æ©æ§ãCovid-19以åãããããªã¬ãŒããåŸ ã£ãŠãããšããææã ãååœæ¿åºã¯ãåäžæŒç¿ïŒtabletop exercisesïŒãã§ãã³ãããã¯å¯Ÿå¿ãäºåèšç·ŽãããEUAïŒç·æ¥äœ¿çšèš±å¯ïŒãšPREPæ³ïŒå 責æªçœ®ïŒã«ãã£ãŠæ³çéå£ã¯ãããããé€å»ãããŠããã圌女ã¯å·åŸ¹ã«æžãã
ãããæŠæŒ¢ã§SARS-CoV-2ãåºçŸããªãã£ããšããŠããå¥ã®å Žæã§å¥ã®ããªã¬ãŒäºè±¡ãèµ·ããŠããã ããââãããŠäžççãã³ãããã¯å¯Ÿå¿ã¯åãã ã£ãã

2 2020幎2æ4æ¥ââãåœå®¶å®å šä¿éäžã®è åšãã®åµåº
ããåœé²ç·çã2020幎2æ4æ¥ãææè 11äººã»æ»è 0äººã®æç¹ã§ã補è¬äŒç€Ÿã®é圹ãã¡ã«ãæ°åã³ãããŠã€ã«ã¹ã¯åœå®¶å®å šä¿éäžã®è åšã ããšåããŠããã®ãªãââå ¬è¡è¡ç以å€ã®çç±ããã£ãã«éããªãã
æ¬æžç¬¬5ç« ã§ã©ãŒãã³ãæç€ºãããã®æ¥ä»ã¯ãå šç·šãéããŠæãäžæ°å³ãªèšŒæ ã®äžã€ã ã
2020幎2æ4æ¥ãç±³åœå ã®ææè ã¯11äººãæ»è ã¯0人ããšãããåœé²ç·çã¯ã¢ã¹ãã©ãŒãã«ã®å¹¹éšã«é»è©±ããããSARS-2ãŠã€ã«ã¹ããåœå®¶å®å šä¿éäžã®è åšãããããããšéåããã忥ãFDAãšHHSã¯EUAïŒç·æ¥äœ¿çšèš±å¯ïŒãšPREPæ³ïŒå ¬è¡è¡çç·æ¥äºæ æºåæ³ïŒã®çºåæ ¹æ ã宣èšãããã«åæ¥ããã¡ãŠããšãã©ã³ã·ã¹ã»ã³ãªã³ãºãã¯ããŠã€ã«ã¹ããå®éšå®€èµ·æºã§ã¯ãªãããšäž»åŒµãã声ææã®èª¿æŽãå§ããŠããã
ããã§çè§£ãã¹ãã¯EUAã®æ³çæ§æ Œã ãããã¯2004幎ã®ççœèããäºä»¶åŸã«å¶å®ãããå¶åºŠã§ãååŠã»çç©ã»æŸå°ç·ã»æ žïŒCBRNïŒå µåšã«ããæ»æãžã®ç·æ¥å¯Ÿå¿ãšããŠèšèšãããŠãããèªç¶çºçã®ææçã§ã¯ãªããçç©å µå𿻿ãžã®å¯ŸåŠæ³ãªã®ã ã
ã€ãŸãSARS-CoV-2ã«å¯ŸããŠEUAãé©çšãããç¬éããã®ãŠã€ã«ã¹ãžã®å¯Ÿå¿ã¯å¶åºŠäžãçç©å µåšãå«ãCBRNè åšãšåäžã®æ³çæ çµã¿ã§åŠçãããããšã«ãªã£ããã©ãŒãã³ã¯ãã®äžç¹ããããã³ãããã¯å¯Ÿå¿ã®å šäœåããå ¬è¡è¡çã®æ çµã¿ã§ã¯ãªãã£ãããšæããã
ããã«mRNAã¯ã¯ãã³ã®èª¿éå¥çŽãããã®ä»ååŒæš©éïŒOTAïŒãââæ¬æ¥ã¯æŠåšãè»äºã·ã¹ãã ã®è¿ é調éã®ããã«èšèšãããè»äºèª¿éã·ã¹ãã ââãéããŠè¡ãããŠããäºå®ãææãããæ³çã«èšãã°ãmRNAã¯ã¯ãã³ã¯ãæŠåšã·ã¹ãã ã®è©ŠäœåããšããŠåé¡ãããŠããã®ã ãOTAã®äžã§ã¯ãéåžžã®å»è¬åã«é©çšãããå®å šæ§åºæºãèšåºè©Šéšã®æ³çèŠä»¶ãäžåé©çšãããªãã
3 2020幎2æ27æ¥ââäžçåæãããã¬ã³ãçºå
2æ27æ¥ã¯æ¥µããŠæ³šç®ãã¹ãæ¥ä»ã ãè¡æçãªãã©ãã£ãã®å転ãèµ·ããæ¥ã ããã ã
ã©ãŒãã³ãããããã¬ã³ãæ©æ¢°ã®åãæ¿ãããšåŒã¶ç¬éãã2020幎2æ27æ¥ã«èµ·ããããã®æ¥ãäžçäžã§åæã«ãã©ãã£ããå転ããã®ã§ããã
忥2æ26æ¥ããã¡ãŠãã¯ãæãããªããšçºèšããŠããããããç¿27æ¥ã«ã¯ã瀟äŒçè·é¢ããã¬ã¯ãŒã¯ãåŠæ ¡ééããžãš180床転æããã忥ãäžé¢æ å ±å§å¡é·ãªãã£ãŒãã»ããŒã¯éå ¬éäŒåã§ã1918幎ãã³ãããã¯äžŠã¿ããè»äºåå¡ã®å¯èœæ§ããäºåãããã©ã»ããŒã¯ã¹ãCovid察å¿èª¿æŽå®ã«ä»»åœãããã
åœéçã«ãåæå€çºçãªåãããã£ããè±åœã§ã¯åŠæ ¡ã»ãªãã£ã¹ééã®æºåçºè¡šããªãŒã¹ãã©ãªã¢ã§ã¯ãã¹ã¿ãžã¢ã éé¢ãšå€§éã¯ã¯ãã³æ¥çš®ãèšç»ãçºåãæ¥æ¬ã§ã¯å šåœäžæäŒæ ¡ã決å®ãEUã§ã¯çµ±åæ¿æ²»å±æ©å¯Ÿå¿ïŒIPCRïŒã®ããã«ã¢ãŒãããçºåãããã

忥ãè€æ°ã®ãããã¬ã³ãã»ããŒã¹ãçºè¡šãããŠãããããŒã¿ãŒã»ãã¶ãã¯ã®ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºè«èª¬ãçŸç Xã®å°æ¥ãããŒã€ãããã»ãã¥ãã§ãã¯ãã®ãµã€ãšã³ãã£ãã£ãã¯ã»ã¢ã¡ãªã«ã³èšäºãæ²ç·å¹³åŠåããããªã¥ãŒã»ããªã¹ã®ãæ²ç·å¹³åŠåããã€ãŒãââãããããã¹ãŠãåãäžæ¥ã«éäžããã
ã©ãŒãã³ã¯åãããããã®åºæ¥äºãå¶ç¶åäžæ¥ã«èµ·ãã確çã¯ã倩æåŠçã«äœãã®ã§ã¯ãªããããããŠåœŒå¥³ã¯çãããããã¯ãåœéçãªèª¿æŽãããè¡åãã§ãããNSCããã®åæ¥ãŸã§ã«ãã¹ãŠã®Covidã³ãã¥ãã±ãŒã·ã§ã³ãã¿ã¹ã¯ãã©ãŒã¹çµç±ã«çµ±å¶ããŠããã®ã ããšã
4 誰ã宿š©ãæ¡ã£ãŠããã®ãââNSCãFEMAããããŠããŒã¯ã¹
ç§ã¯åœŒããç§åŠè ã®ããã«æ¯ãèãã®ãäžåºŠãèŠãªãã£ããæ¿ççºè¡šã®æ ¹æ ãšãªã£ããã¬ã³ããæ€èšŒããããã«æ°åãæãäžããããšãªã©ãäžåºŠããªãã£ãã®ã ã
æ¬æžã®æ žå¿ç䞻匵ã®äžã€ã¯ããã³ãããã¯å¯Ÿå¿ã®å®è³ªçæ±ºå®æš©ãå ¬è¡è¡çæ©é¢ã§ã¯ãªãåœå®¶å®å šä¿éäŒè°ïŒNSCïŒã«ãã£ããšããç¹ã ã

ã©ãŒãã³ã蚌æ ãšããŠæããã®ãPanCAP-AææžïŒ2020幎3æ13æ¥ïŒã§ããããã®ææžã®çµç¹å³ã§ã¯ãNSCãæäžäœã§æ¿çæ±ºå®æš©ãæã¡ãHHSã¯ã調æŽã圹ã«çž®å°ãããŠããã2020幎3æ18æ¥ã«ã¯ãFEMAïŒé£éŠç·æ¥äºæ 管çåºïŒãHHSã«ä»£ãã£ãŠãäž»å°é£éŠæ©é¢ïŒLFAïŒãã«ä»»åœãããââå°éã»ç«çœå¯Ÿå¿çšã«èšèšãããæ©é¢ããå ¬è¡è¡ç察å¿ã®ææ®ãå·ãããšã«ãªã£ãã®ã ãCDCã¯2020幎3æãã6æãŸã§ãã¬ã¹ããªãŒãã£ã³ã°ãçŠæ¢ãããã

ãã®æš©åæ§é ã®äžã§ããã©ã»ããŒã¯ã¹ãæããã圹å²ããã©ãŒãã³ã¯ç¹ã«éèŠãããããŒã¯ã¹ã¯HIV/AIDSç ç©¶è ã§ãããç«åŠãæ°åç åäœå¯Ÿå¿ã®çµéšã¯ãªãã£ãã圌女ãNSCã®ãããã»ãããã£ã³ãžã£ãŒïŒå¯Ÿäžå¯åœå®¶å®å šä¿éé¡§åïŒãä»»åœããã®ã¯ãã圌ãã®èŠåã匷åãããããã ã£ãââããŒã¯ã¹èªèº«ãåŸã«èªããŠããéãã ã
ã¹ã³ããã»ã¢ãã©ã¹ã®èšŒèšã決å®çã§ããããç§ã¯åœŒããç§åŠè ã®ããã«æ¯ãèãã®ãäžåºŠãèŠãªãã£ããæ¿ççºè¡šã®æ ¹æ ãšãªã£ããã¬ã³ããæ€èšŒããããã«æ°åãæãäžããããšãªã©ãäžåºŠããªãã£ãã®ã ãã
å ¬éããããã¡ãŠãã®æ¥èšã¯ãæ¬æžã®åæãè£åŽããæ€èšŒããçšæãªäžæ¬¡è³æã§ãããæ¥èšã®äžã§ãã¡ãŠãã¯ã2020幎2æåé ã®æç¹ã§ããã¹ã¯ã¯äžè¬åžæ°ã«äžèŠããšç¹°ãè¿ãè¿°ã¹ãªããããã®ãããæ°é±éåŸã«ã¯ãåžžã«ãã¹ã¯ççšãå¿ èŠããš180床転æããããšã«ã€ããŠãé©ãã»ã©ç¡é çã§ããã圌ã®é¢å¿ã¯äžè²«ããŠãã¡ãã»ãŒãžã®çµ±å¶ããšãã¯ã¬ãã³ã·ã£ã«ïŒè³æ Œã»æš©åšïŒã®ç¶æãã«åããããŠãããç§åŠçæ ¹æ ã®æšç§»ã«ã€ããŠã®å ççèšè¿°ã¯é©ãã»ã©ä¹ããã
ã©ãŒãã³ãã圌ãã¯ç§åŠè ã®ããã«æ¯ãèãããšãäžåºŠãããªãã£ãããšããã¢ãã©ã¹ã®èšŒèšãåŒããããšã¯ããŸãã«ãã®æ¥èšã«ãã£ãŠè£ä»ããããããšã«ãªããæ¥èšã«çŸãããã¡ãŠãã¯ãç«åŠè ãšããããæ¿æ²»ãªãã¬ãŒã¿ãŒã§ãã£ãã
ã©ãŒãã³ã¯å·åŸ¹ã«çµè«ã¥ããããå ¬è¡è¡çã®å°éå®¶ãã¡ã¯ãã³ãããã¯å¯Ÿå¿æ¿çã«è²¬ä»»ãè² ã£ãŠããªãã£ããè»äºã»è«å ±ã»çç©é²è¡ã®æå°éšãææ¡ããŠããã®ã ã
5 mRNAã¯ã¯ãã³ã®è»äºèµ·æºãšé èœãããæ»äº¡
ãå®å šã§å¹æçããšãã䞻匵ã¯ãå®å šã«æ¿åºè·å¡ã®é¡æã»æèŠã»ä¿¡å¿µã»æšå®ã«åºã¥ããŠããã
æ¬æžç¬¬5ç« ã¯ãmRNAã¯ã¯ãã³ããããæ³å¶åºŠã®åæã«å€ãã®çŽå¹ ãå²ããã©ãŒãã³ã®äž»åŒµã¯ããã ââmRNAãã¯ã¯ãã³ãã¯éåžžã®å»è¬åæ¿èªããã»ã¹ãäžåçµãŠããããè»äºèª¿éã»çç©å µåšå¯Ÿçã®æ³çæ çµã¿ãéããŠåœæ°ã«æäžãããã
æè¡ã®èµ·æºãé¡ããšãmRNAãã©ãããã©ãŒã ã¯DARPAïŒåœé²é«çç ç©¶èšç»å±ïŒã®ããã³ãããã¯é²æ¢ãã©ãããã©ãŒã ïŒP3ïŒãããã°ã©ã ã®äžç°ãšããŠéçºããããDARPAã®2017幎èšç»ã§ã¯ãæ žé žé åãçšããŠ60æ¥ä»¥å ã«ãŠã€ã«ã¹ææã忢ãããçµ±åãšã³ãããŒãšã³ãã»ãã©ãããã©ãŒã ããç®æšãšãããŠãããããã¯æ°åå人ãžã®é·ææäžã§ã¯ãªããéå®çãªè»äºéšéãžã®ç·æ¥æäžãæ³å®ããæè¡ã§ããã

Covid-19ã§ã®é©çšã¯ãã©ãŒãã³ã«ããã°ããã®è»äºæè¡ã®ãæ°é人å£ãžã®ç¡èš±å¯äººäœå®éšãã«ä»ãªããªãããããEUAãšPREPæ³ã«ããæ³çä¿è·ã«ããããã®äººäœå®éšã®çµæã«ã€ããŠèª°ã責任ãè² ããªãå®ç§ãªå 責äœå¶ãæ§ç¯ãããŠããã
æãè¡æçãªæ°åãããã¡ã€ã¶ãŒã®ç€Ÿå ææžããæããã«ãªãã2021幎2æ28æ¥ä»ã®å ±åæžã«ããã°ãæäžéå§ããããã3ã¶æéã§42,086ä»¶ã®æå®³äºè±¡ã®ãã¡1,223ä»¶ã®æ»äº¡ãå ±åãããŠãããæ¯èŒã®ããã«ââJ&Jã®ã¢ãããŠã€ã«ã¹ã¯ã¯ãã³ã¯9ä»¶ã®æ»äº¡äŸã§ã第äžéžæã¯ã¯ãã³ã§ã¯ãªãããšããŠäœ¿çšå¶éããããmRNAã¯ã¯ãã³ã¯ãã®1,000å以äžã®æ»äº¡äŸã«ããããããæšå¥šããç¶ããã
ãã¡ã€ã¶ãŒã®ç€Ÿå è©äŸ¡ã§ã¯ããããã®æ»äº¡äŸã¯ãæ°èŠã®å®å šæ§æžå¿µã§ã¯ãªãïŒæ³å®å ã®æ»è ïŒããšããããã©ãŒãã³ã¯ãã®æèšããæ»äº¡ãªã¹ã¯ãäºåã«æ³å®ãããŠããããšã®èšŒå·Šããšèªã¿è§£ããã¯ã¯ãã³æ¥çš®éå§ããããã3ã¶æã§1,000ä»¶è¶ ã®æ»äº¡ããæ³å®å ããšåŠçãããäºå®ãã®ãã®ãããã®å¶åºŠèšèšã®ç°åžžæ§ãæµ®ã圫ãã«ããŠããããšããã®ã圌女ã®äž»åŒµã ã
6 ããŠã«ãŽã¡ãªã³ãºãã®æ£äœââCIAçç©å µåšå°éå®¶ãããã¯ãŒã¯
å ¬è¡è¡çã¯Covidãã³ãããã¯ã®éãèã«è¿œãããããå ¬è¡è¡çãªãŒããŒãã¡ã¯ä¿¡é Œããããå°éå®¶ããšããŠãçç©æŠäºã®æä»€ãåœæ°ã«äŒããããã«å©çšãããã
ãã€ã±ã«ã»ã«ã€ã¹ã®ãã¹ãã»ã©ãŒããã¬ã¢ãã·ã§ã³ãã¯ãããŠã«ãŽã¡ãªã³ãºããšåŒã°ãã7人ã®å»åž«ã°ã«ãŒããããã¯ããŠã³æ¿çãèæ¡ããè±éãšããŠçŸåãããã©ãŒãã³ã®èª¿æ»ã¯ããã®ç¥è©±ãæ ¹æ¬ããè§£äœããã
ããŠã«ãŽã¡ãªã³ãºãã®äžå¿äººç©ãªãã£ãŒãã»ããã§ããã¯ãå CIAå·¥äœå¡ã§ãããçç©å µåšç ç©¶éçºå±ïŒBARDAïŒã®å 責任è ãææçæµè¡å¯Ÿçã€ãããŒã·ã§ã³é£åïŒCEPIïŒã®CEOã ã£ãã圌ã¯2020幎1æ23æ¥ãšããæ¥µããŠæ©æã«Covid-19ã¯ã¯ãã³éçºãçºè¡šããŠããã
ã«ãŒã¿ãŒã»ã¡ãã·ã£ãŒã¯è¡šåããé圹è»äººç é¢ã®ç¡åå»åž«ããšãããããå®éã¯çç©å µåšã»å€§éç Žå£å µåšã®å°éå®¶ã§ã2015幎ã«ãããœã³ç ç©¶æã§ççœèæ»æã·ããªãªã«ã€ããŠè¬æŒããŠããã圌ã®äžåžãã€ãã£ã»ã¢ãŽãªãŒã¯å CIAå¹¹éšã§ããã
圌ãã¯ãã¯ããå»åž«ãã©ããããCIAã»è»äºã»çç©å µåšç ç©¶ã®äžæ žãæ ãå°éå®¶éå£ã ã£ããã©ãŒãã³ã®åæã¯å®¹èµŠãªãââã«ã€ã¹ã®æ¬ã¯ãçç©é²è¡ãããã¯ãŒã¯ã®ãããã¬ã³ãäœåãã§ãããå ¬è¡è¡çãªãŒããŒãã¡ïŒãã¡ãŠããã¯ã¬ã³ã¹ããŒããããºãããã¹ãã³ãããã«ïŒã¯ãæãã ã£ããã®ã§ã¯ãªããçç©é²è¡ã¢ãžã§ã³ãã®ãã¡ãã»ã³ãžã£ãŒããšããŠå©çšãããã®ã ã
7 ãªã©ã³ããšãã€ãââNATOåçåœã§ç¢ºèªãããè»äºçµ±å¶
極ããŠåŒ·åãªå¢åããç±³åœãšEUã«å¯Ÿããç±³åœéžæãŸã§Covidã¯ã¯ãã³æ¿èªã®ææãé ãããããåœããã
æ¬æžã®åœéæ¯èŒåæã¯ããã®æ§é ãç±³åœã ãã®çŸè±¡ã§ã¯ãªãããšã瀺ãã
ãªã©ã³ãã§ã¯ãä¿å¥å€§è£ãã«ãŒã«ã»ã¢ããã2024幎11æã®è°äŒèšŒèšã§å ¬åŒã«èªããââããªã©ã³ãã®ãã³ãããã¯æ¿çã¯åœå®¶ãã察çã³ãŒãã£ããŒã¿ãŒïŒNCTVïŒãšåœé²çã®ææ®äžã§è¡ãããNATO矩åã«åŸããªããã°ãªããªããã
NCTVã¯æ°äž»çããã»ã¹ã®äžå€®éæš©åãè°äŒã§ã®è³ªçå¿çã®çµ±å¶ãåœæ°ç£èŠã®ããã®è»äºéšéïŒLIMCïŒã®åµèšãè¡åç§åŠãçšããå¿çæäœãã£ã³ããŒã³ã宿œããŠããã
ãã€ãã§ã¯ãããã«ãã»ã³ããç ç©¶æïŒRKIïŒã®å éšææžãªãŒã¯ãããã«è¡æçãªäºå®ãæŽé²ããããã³ãããã¯æ¿çã®å®è³ªçæ±ºå®æš©ã¯ãRKIæé·ãŽã£ãŒã©ãŒã®2éå±€äžã«ããNATOå°è»ãã«ã¿ãŒã ã«ãã£ãã
RKIææžã«ã¯ãFDAã«ããç±³åœéžæåã®æ¿èªã¯æãŸãããªããæ¬§å·åœå±ãåæ§ã§ãããã€ãŸã11æåã«æåã®çµæã¯åŸãããªãããšããèšè¿°ããããã¯ã¯ãã³æ¿èªã®ã¿ã€ãã³ã°ãç§åŠçæ ¹æ ã§ã¯ãªãæ¿æ²»çææã§æ±ºå®ãããŠããããšã瀺ããŠããã
ã©ãŒãã³ã¯ãããããååœã®å ¬è¡è¡çæ¿çãå®éã«ã¯è»äºåçã®æŠç¥ç決å®ã ã£ãããšãå ¬åŒã«èªããã蚌æ ãšããŠäœçœ®ã¥ããã

8 ãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ââãå¥åº·ç ç©¶ããè£ ã£ãè»äºã»è«å ±æŽ»å
æ©èœç²åŸç ç©¶ïŒGOFïŒã§ç¥ãããããŒã¿ãŒã»ãã¶ãã¯ã®ãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãã©ãŒãã³ããã®è³éæºãåæãããšããå¥åº·ç ç©¶ãçµç¹ã®å®è³ªçæ§æ Œãæµ®ãã³äžããã
ç·é¡1å1,800äžãã«ã®æ¿åºè³éã®ãã¡ã4,200äžãã«ãåœé²ç·çããã6,500äžãã«ãUSAIDïŒCIAä»£çæ©é¢ïŒããââå ¬è¡è¡çæ©é¢ããã®è³éã¯çžå¯Ÿçã«å°æ°ã ã£ããRFK Jr.ã®ãThe Wuhan Cover-UpããåŒçšãã€ã€ãã©ãŒãã³ã¯ããã¶ãã¯ã®æå€§ã®è³éæºã¯CIAã®ä»£çæ©é¢ã§ããUSAIDã ã£ãããšææããã
ãã¶ãã¯ã®2020幎2æ27æ¥ä»ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºè«èª¬ãçŸç Xã®å°æ¥ãã¯ããã®æèã§èªããšæ±ºå®çãªèšŒæ ãšãªãããã³ãããã¯å®£èšåã«æ¢ã«SARS-CoV-2ããçŸç Xããšæå®ããmRNAéºäŒåãã©ãããã©ãŒã ã«ãã察çã®å¿ èŠæ§ã瀺åããŠãããã©ãŒãã³ã¯ããããå¶ç¶ã®äºæž¬ã§ã¯ãªããäºåã«èšç»ãããã·ããªãªã®å®è¡ããšæããã
GOFç ç©¶ãšå»ç察çïŒmRNAã¯ã¯ãã³ïŒã¯ãã©ãŒãã³ã®åæã§ã¯ãåäžã®çç©é²è¡ã»çç©æŠäºã¹ããŒã ã®äºåŽé¢ãã§ãããè åšãåµåºããåŽãšããã®è åšã«å¯Ÿããã解決çããæäŸããåŽââäž¡è ã¯åãè³éæºãšäººèã§çµã°ããŠããã
9 AIæ€é²ãšãèªå·±æ€é²ããåžæ°ãââæ å ±æŠäºã®æçµåœ¢æ
ãã¯ã誰ãããªããæ€é²ããå¿ èŠã¯ãªããããªããèªåã§èªåãæ€é²ããã®ã ã
æ¬æžç¬¬4ç« ã¯ããã³ãããã¯ãšåæäžŠè¡ã§é²è¡ããæ å ±çµ±å¶ã®å®æ ãæãã
ã©ãŒãã³ãæãè¡æçãšäœçœ®ã¥ããã®ãããã·ã¬ã³å€§åŠãåœç«ç§åŠè²¡å£ïŒNSFïŒã«ææ¡ããAIæ€é²ããŒã«ãWiseDexãã®èª¬æææžã ãããã«ã¯é²éªšã«ããæžãããŠããââãæã ã®èª€æ å ±ãµãŒãã¹ã¯ããã©ãããã©ãŒã ã®æ¿çç«æ¡è ãæ€é²ã®å°é£ãªå€æè²¬ä»»ãå€éšã«æŒãä»ããããšãæ¯æŽããããã誀æ å ±ãµãŒãã¹ããšãæ€é²ãã®åäžèŠããå ¬ææžã§æç€ºãããŠããã®ã§ããã

ãã®ã·ã¹ãã ã®æãããã¯ã人çå¶çŽã®å®å šãªé€å»ã«ãããåŸæ¥ã®æ€é²ã¯äººå¡ã®éçã«ããå°èŠæš¡ã«ãšã©ãŸã£ãŠããããAIã·ã¹ãã ã¯çè«äžç¡å¶éã®ç£èŠå¯Ÿè±¡ãåŠçã§ããããããæ€é²æ±ºå®ãæ©æ¢°ãè¡ããããèª°ãæ³çã»é埳ç責任ãè² ããªãå®ç§ãªå 責äœå¶ãæ§ç¯ãããã
ã©ãŒãã³ã¯ããã«ã1996幎ã®ãžã§ã³ã»ããªãŒã»ããŒããŠããµã€ããŒç©ºéç¬ç«å®£èšããã2022幎ã®ãã€ã³ã¿ãŒãããã®æªæ¥ã®ããã®å®£èšããžã®å€é·ã远ãããèªç±ããšããèšèãã¿ã€ãã«ããæ¶ããããã«ãã¹ããŒã¯ãã«ããŒãã¢ãããŒãã«çœ®ãæããããããšãææãããWikipediaã¯CIAã«ä¹ã£åãããå¯èœæ§ãããïŒå ±ååµèšè ã©ãªãŒã»ãµã³ã¬ãŒã®äž»åŒµïŒããããŠæçµçã«åžæ°ã¯ãèªå·±æ€é²ããžãšè¿œã蟌ãŸããââããã¯ã誰ãããªããæ€é²ããå¿ èŠã¯ãªããããªããèªåã§èªåãæ€é²ããã®ã ãã
CIAã¯ãŠã£ãããã£ã¢ãç·šéããŠããââå ±ååµèšè ãèªãæ å ±å·¥äœã®èšŒæ
â 䞊è¡å³æž / Parallel Library | Alzhacker (@Alzhacker) August 2, 2026
ãŠã£ãããã£ã¢ã®å ±ååµèšè ã©ãªãŒã»ãµã³ã¬ãŒãã2025幎1æã®ããããã£ã¹ãã§é倧ãªåçºãè¡ã£ããCIAãã¯ãããšããæ å ±æ©é¢ããåãã©ãããã©ãŒã ã®ç·šéã«çµç¹çã«é¢äžããŠãããšããã®ã ã⊠pic.twitter.com/nszFlT5GG0
çµè«ââæ¬¡ã®ãç·æ¥äºæ ããæ¥ããšããæ¥æ¬ã§
ã©ãŒãã³ã¯æ¬æžãåãªãéå»ã®åçºã§çµããããŠããªãã圌女ãæãèŠæããã®ã¯ãæ°žç¶çç·æ¥äºæ äœå¶ãã®ç¢ºç«ã§ãããWHOã®ãã³ãããã¯æ¡çŽããæ°åç·æ¥äºæ ããããµã€ããŒãã³ãããã¯ãããæ å ±ãã³ãããã¯ãââæ¬¡ã ãšæ°ãããå®åçè åšããåµé ããããã®åºŠã«æ°äž»ççµ±å¶ãè¿åããç·æ¥æš©åãçºåãããä»çµã¿ãããã§ã«æ§ç¯ãããŠããã
ãããŠããã®æ§é ãæ¥æ¬ã«ãšã£ãŠå¯Ÿå²žã®ç«äºã§ãªãããšã¯ãæ¬æžã®åœéæ¯èŒåæãéåŒã«ç€ºããŠãããæ¥æ¬ã®Covid察å¿ãæ¯ãè¿ãã°ã2020幎2æ27æ¥ã®å šåœäžæäŒæ ¡èŠè«ã¯ãã©ãŒãã³ããäžçåæãããã¬ã³ãçºåããšåæãããã®æ¥ãšæ£ç¢ºã«äžèŽãããç¹æªæ³æ¹æ£ã«ããç§æš©å¶éã®æä¹ åãããžã¿ã«åºåµèšãšãã€ãã³ããŒä¿éºèšŒã®åŒ·è¡ãææç屿©ç®¡ççµ±æ¬åºã®æ°èšââãããã¯ãã¹ãŠããã³ãããã¯ãæ¢åã«ãã統治æ§é ã®åç·šã§ããããæ°žç¶çç·æ¥äºæ äœå¶ãã®æ¥æ¬çã«ã»ããªããªãã

æ¥æ¬ã®ã¡ãã£ã¢ã¯ãã®æ§é ãæ€èšŒããããåçåŽåçã®å°éå®¶äŒè°ãå®éã«ã¯ã©ã®ææ®ç³»çµ±ã§åããŠããã®ããmRNAã¯ã¯ãã³ã®èª¿éã«è»äºèª¿éé¡äŒŒã®ä»çµã¿ã䜿ãããªãã£ãã®ãââããããçåã¯ãã»ãŒåãããããšãªããæ¬¡ã®ç·æ¥äºæ ãã®æºåãé²ããããŠããã
ã©ãŒãã³ãèªè ã«ææž¡ãã®ã¯çµ¶æã§ã¯ãªãã圌女ã¯ç¬¬6ç« ã§ãä»åŸã®èª¿æ»ã®ããã®è³ªåããåæãã第4ç« ã§ã¯ãèšè«ã®èªç±ã ãããæš©åè ã«å¹³åçã«èª¬æè²¬ä»»ãæããããå¯äžã®æ¹æ³ã ããšæžããããã¯è¡åãžã®åŒã³ããã§ãããæ¥æ¬ã®èªè ã«ãšã£ãŠã¯ãªãããåå®ãªæå³ãæã€ââæ¥æ¬èªåã§ã¯æ¬æžã®ãããªäœç³»çãªèª¿æ»å ±åã¯æªã çãŸããŠããªãããã ã
次ã®ãç·æ¥äºæ ãã宣èšããããšããç§ãã¡ã¯ç«ã¡æ¢ãŸã£ãŠåãããšãã§ããã ããããããã¯æ¬åœã«å ¬è¡è¡çã®å±æ©ãªã®ãããããšãå¥ã®äœããªã®ããäžæäŒæ ¡ããã¹ã¯ãã¯ã¯ãã³ãããã¯ããŠã³ãä»£æ¿æ²»çè¬ãžã®åŒŸå§ââãã®æããããããããªãã£ãããšé£²ã¿èŸŒãã ãã¹ãŠã®æªçœ®ã®èåŸã«ã誰ãããŠãã©ã®ãããªæ³çæ çµã¿ãäºåã«çšæãããŠããã®ãã
æ¬æžã¯ãã®åããç«ãŠãããã®ãææžèšŒæ ã«åºã¥ããæŠåšã§ããããããŠãã®æŠåšãæ¥æ¬èªã«ç§»ãæ¿ãããã®åœã®æèã§æ€èšŒãå§ããããšã¯ãç§ãã¡èªèº«ã«å§ããããŠããã
åèæç®ãªã¹ã
äžæ¬¡è³æïŒæ³åŸã»æ¿åºææžïŒ
Project Bioshield Act of 2004, Public Law 108-276
Public Readiness and Emergency Preparedness (PREP) Act, 42 U.S.C. § 247d-6d
DARPA, Pandemic Prevention Platform (P3) Program, Broad Agency Announcement (2017)
PanCAP-A document, March 13, 2020ïŒç±³åœæ¿åºå éšææžââNSCã«ãããã³ãããã¯å¯Ÿå¿ææ®ç³»çµ±å³ïŒ
FDA, Emergency Use Authorization of Medical Products and Related Authorities, Guidance (January 2017, revised March 2020)
Pfizer, Cumulative Analysis of Post-Authorization Adverse Event Reports (February 28, 2021)ïŒFDAæåºç€Ÿå ææžââ3ã¶æéã§42,086ä»¶ã®æå®³äºè±¡ããã¡1,223ä»¶ã®æ»äº¡ãå ±åïŒ
Robert Koch-Institut (RKI), Internal Risk Assessment Document (March 16, 2020)ïŒå éšãªãŒã¯ææžââã¯ã¯ãã³æ¿èªææã®æ¿æ²»ç調æŽãæç€ºïŒ
WHO, Zero Draft of the WHO Convention, Agreement or Other International Instrument on Pandemic Prevention, Preparedness and Response (WHO CA+) (February 1, 2023; revised 2024)
U.S. Government Accountability Office (GAO), Bioterrorism: Federal Research and Preparedness ActivitiesïŒå幎çãç¹ã«2001-2005å¹Žã®æ¥å¢æïŒ
National Science Foundation, Award Abstract #2123635: SCC-CIVIC-PG Track B: WiseDex: A Platform for Curbing the Spread of MisinformationïŒãã·ã¬ã³å€§åŠãžã®å©æéæŠèŠââãæ€é²ã®å€éšåãæèšãå«ãïŒ
æ°åã€ã³ãã«ãšã³ã¶ç察çç¹å¥æªçœ®æ³ïŒå¹³æ24幎æ³åŸç¬¬31å·ã什å2å¹Žæ¹æ£ïŒ
å é£å®æ¿ãæ°åã³ãããŠã€ã«ã¹ææçå¯Ÿçæ¬éšïŒç¬¬15åïŒè°äºé²ãïŒä»€å2幎2æ27æ¥ïŒââå šåœäžæäŒæ ¡èŠè«ã®æ±ºå®ææž
è°äŒèšŒèš
Fleur Agema, Minister of Health, Netherlands, Parliamentary Testimony (November 2024)ââããªã©ã³ãã®ãã³ãããã¯æ¿çã¯NCTVïŒåœå®¶ãã察çã³ãŒãã£ããŒã¿ãŒïŒãšåœé²çã®ææ®äžã§è¡ãããNATO矩åã«åŸã£ãããšã®å ¬åŒèšŒèš
Dominic Cummings, Former Chief Adviser to UK Prime Minister, Parliamentary Testimony (May 26, 2021)ââãPlan A / Plan BãæŠç¥ãšç§åŠé¡§åã°ã«ãŒãã®æ¿æ²»çæ©èœã«é¢ãã蚌èš
æžç±
Debbie Lerman, The Deep State Goes Viral: Pandemic Planning and the Covid Coup (Brownstone Institute, 2025)
Scott Atlas, A Plague Upon Our House: My Fight at the Trump White House to Stop COVID from Destroying America (Bombardier Books, 2021)
Robert F. Kennedy Jr., The Wuhan Cover-Up: And the Terrifying Bioweapons Arms Race (Skyhorse Publishing, 2023)
Michael Lewis, The Premonition: A Pandemic Story (W.W. Norton, 2021)ââããŠã«ãŽã¡ãªã³ãºãç¥è©±ã®åå žïŒæ¹å€å¯Ÿè±¡ãšããŠïŒ
Lynn C. Klotz & Edward J. Sylvester, Breeding Bio Insecurity: How U.S. Biodefense Is Exporting Fear, Globalizing Risk, and Making Us All Less Secure (University of Chicago Press, 2009)
Renée DiResta, Invisible Rulers: The People Who Turn Lies into Reality (PublicAffairs, 2024)ââã誀æ å ±å¯Ÿçç£æ¥ãå éšããã®åçº
Matt Taibbi, The Twitter FilesïŒ2022-2023ïŒââFBIã»CIAã»DHSãšãœãŒã·ã£ã«ã¡ãã£ã¢ã®æ€é²ååäœå¶ã«é¢ããå éšææžã·ãªãŒãº
Giorgio Agamben, State of Exception (University of Chicago Press, 2005; Italian original 2003)
Giorgio Agamben, Where Are We Now? The Epidemic as Politics (ERIS, 2021; Italian original 2020)
è«æã»è«èª¬
Michael Lofgren, ãAnatomy of the Deep Stateã, BillMoyers.com (February 21, 2014)
George J. Annas, ãBioterrorism, Public Health, and Civil Libertiesã, New England Journal of Medicine, Vol. 346, No. 17 (April 25, 2002), pp. 1337-1342
Crystal Franco & Tara Kirk Sell, ãFederal Agency Biodefense Funding, FY2013-FY2022ã, Health Security, Vol. 20, No. 3 (2022), pp. 212-221
ããŒã¿ããŒã¹ïŒãªã³ã©ã€ã³ïŒ
USAspending.govââEcoHealth Allianceé£éŠè³éåé èšé²ïŒåœé²ç·çã»USAIDã»NIHããã®å¥çŽã»å©æéãçåºå¥ã«æ€çŽ¢å¯èœïŒ
NIH Research Portfolio Online Reporting Tools (RePORT)ââEcoHealth Allianceãžã®GOFç ç©¶é¢é£å©æéäžèЧ
OpenTheBooks.comââEcoHealth Alliance Federal Funding SnapshotïŒæ¿åºæ¯åºç£èŠNPOã«ããè³éæºå¯èŠåïŒ
Moderna, Inc., SEC Form 10-KïŒ2019-2020幎床ïŒââBARDAã»DARPAãšã®OTAå¥çŽé¢ä¿ãé瀺
Department of Defense, Other Transaction Authority (OTA) Agreements ListingsââPfizer/BioNTechãModernaãšã®OTA調éå¥çŽã®å ¬éããŒã¿ããŒã¹
åœéæ©é¢ææž
WHO, Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) (January 30, 2020)ââPHEIC宣èšã®å ¬åŒå£°æ
European Centre for Disease Prevention and Control (ECDC), Risk Assessment: Outbreak of Novel Coronavirus Disease 2019 (COVID-19)ïŒ2020幎2æ12æ¥çã3æ2æ¥çïŒââEUãªã¹ã¯è©äŸ¡ã®ç·æ¥ã¢ãŒããžã®åãæ¿ãããæ¥ä»ã§è¿œè·¡
NATO, Civil Emergency Planning: Resilience and Article 3ââãã³ãããã¯ãžã®NATOææ°ç·æ¥æèšç»ã®é©çšã«é¢ããææž